The Joplin Globe, Joplin, MO

Business

April 3, 2013

Monsanto profit rises 22 percent in second quarter

WASHINGTON — Monsanto reported Wednesday that its income increased 22 percent in the agriculture products company’s second quarter on strong sales of biotech seeds, particularly in Brazil and other emerging markets.

The company boosted its full-year earnings guidance, citing its strong performance in the first half of the year.

Its shares rose 2 percent in morning trading.

The St. Louis company said it earned $1.48 billion, or $2.74 per share in the three months ended Feb. 13, up from $1.21 billion, or 2.24 per share, in the same quarter a year ago.

Monsanto Co.’s sales increased 15 percent to $5.47 billion, led by genetically modified corn seeds, the company’s best-selling product.

The company’s results topped Wall Street predictions of $2.56 per share on sales of $5.27 billion, according to FactSet.  

Monsanto executives raised their full-year earnings outlook to between $4.40 and $4.50 per share, up from $4.30 to $4.40. Analysts expect earnings of $4.56 per share.

Monsanto has dominated the bioengineered-seed business for more than a decade. In recent years the company has focused on growing business in emerging markets like Argentina, Brazil and other Latin American countries.

The company’s corn, soybean, cotton and other seeds have genetically engineered traits that repel bugs, increase yield and make them resistant to weed-killer. The company says these benefit farmers enough that they come out ahead, even though the seeds cost more than conventional seeds. Monsanto’s critics argue that the company has tried to use patent law to control the supply of seeds for soybeans, corn, cotton, canola and other agricultural staples. Monsanto has a policy that prohibits farmers from saving or reusing the seeds once a crop is grown

Last month the Supreme Court heard a case between Monsanto and an Indiana farmer who replanted the company’s herbicide-resistant soybeans after buying them second hand. The court appeared likely to side with Monsanto Co. in its claim that the farmer violated the company’s patents on the soybean technology.

Sales of the company’s seeds business increased more than 10 percent to $4.3 billion in the second quarter. Sales of the company’s agricultural productivity unit, which sells pesticides and herbicides, increased 36 percent to $1.1 billion.

Monsanto historically made most of its money from chemicals, including the herbicide Roundup. But Roundup isn’t as profitable as it used to be, in part because competition from generic products from China and other nations has dragged down the price Monsanto can charge.

Monsanto shares rose $2.03, or 2 percent, to $105.65 in morning trading. They are near the high end of the 52-week range of $69,70 to $106.61.

 

1
Text Only
Business
Poll

Do you think Missouri should pass legislation that would allow a prescription drug database to be kept?

A. Yes.
B. No.
     View Results
Facebook
Twitter Updates
Follow us on twitter
NDN Video
US Airlines Cancel Israel Flights Obama Signs Workforce Training Law Crash Victims' Remains Reach Ukraine-held City Diplomatic Push Intensifies to End War in Gaza Obama Offers Condolences at Dutch Embassy Cat Fans Lap Up Feline Film Festival Raw: Lawmakers Scuffle in Ukraine's Parliament The Rock Finds His Inner 'Hercules' Michigan Plant's Goal: Flower and Die Raw: MH17 Passenger Remains in Kharkiv, Ukraine Raw: Israel Hits Gaza Targets, Destroys Mosques ShowBiz Minute: Hoffman, Oberst, Box Office WWII Vet Gets Medals, 70 Years Late Raw: Israel Bombs Multiple Targets in Gaza Veteran Creates Job During High Unemployment Raw: Cargo Craft Undocks From Space Station Widow: Jury Sent Big Tobacco a $23B Message New Orleans Plans to Recycle Cigarette Butts UN Security Council Calls for MH 17 Crash Probe Obama Bestows Medal of Honor on NH Veteran